The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $11.
Arcos Dorados Holdings Inc.
ARCO · the NYSE · USD · Market cap $1.7B
FAIL · Does not pass the screenAt the last full screen
2026-09-07
Screened 2026-09-07 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
Arcos Dorados Holdings Inc. holds its Accumulation at $8.17. Consolidating, no directional conviction, held for 10 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 10 days |
| Price at the screen | $8.17 |
| Valuation | 6.64 trailing · 9.50 forward price to earnings |
| Values screen | FAIL |
| Beta | 0.49 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 131.11% | Below 33% | Interest-bearing debt is 131.1% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 24.66% | Below 33% | Cash held in interest-bearing accounts and securities is 24.7% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 65% discount to our $13.49 fair value, moderate competitive moat, 14.30% revenue growth.
Fair value range in USD, drawn from the 2026-09-07 screen. The gold marker is the market price at the same screen. A 65.1% margin of safety to the base estimate.
Third-party analyst targets: 9 covering, consensus Buy. The average target sits +41% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-07 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsLatin America's biggest McDonald's franchisee fails on debt
Picture a queue for burgers stretching from Sao Paulo to Mexico City. Arcos Dorados runs those outlets, yet its balance sheet already carries more leverage than our screens allow. The business posts 13% revenue growth and a 36% return on equity, yet profit margins sit at just 5% and the ethical screen flags the debt ratio immediately. That single failure rules the name out before any valuation debate begins.
We pass for two clear reasons. First, the debt breach sits outside our tolerance regardless of the 9.7 times forward earnings multiple or the 58% gap to our fair value. Second, consumer cyclical exposure means today's low multiple can simply mark peak earnings rather than a bargain. Analyst targets cluster near 12 dollars, but none of that offsets the ethical red line.
Risk sits around leverage in volatile currencies and thin margins that leave little room for shocks. The moat is only moderate and offers no protection once debt service costs rise. Analysis, not advice.
| Forward P/E | 9.5xcheap for a company growing this fast |
| Trailing P/E | 6.6xvery cheap relative to earnings |
| EPS, trailing | 1.23 |
| EPS, forward | 0.86 |
| Revenue growth | +14.3%steady growth |
| Profit margin | 5.2%thin but positive margins |
| Return on equity | 36.4%an exceptional return on shareholder capital |
| FCF yield | 7.49% |
| Dividend yield | 344.00% |
| Debt to equity | 2.64heavy leverage: higher risk if revenue softens |
| Current ratio | 0.88below 1: short-term bills exceed liquid assets |
| Beta | 0.49barely tracks the market's swings |
| Short interest, float | 0.03% |
| 52-week range | 6.54 - 9.75 |
| Moat | MODERATE |
| Market cap | $1.7B |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeARCO trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 0.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $11.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $11.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $11.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-08 | STATON WOODS W. | Officer and Director | 58,207 | · | |
| 2026-05-08 | TANNENBAUM MARIANO | Chief Financial Officer | 22,526 | · | |
| 2026-05-08 | GONZALEZ AVILA CARLOS EDUARDO | Chief Operating Officer | 7,522 | · | |
| 2026-05-08 | RAGANATO LUIS ALBERTO | Chief Executive Officer | 24,239 | · | |
| 2026-05-08 | STATON FRANCISCO ALBERTO | Director | 13,033 | · | |
| 2026-04-30 | CHU MICHAEL | Director | 4,988 | · | |
| 2026-04-30 | FRANQUI ANNETTE V | Director | 4,988 | · | |
| 2026-04-30 | FERNANDEZ JOSE RAUL | Director | 4,988 | · | |
| 2026-04-30 | ALONSO SERGIO DANIEL | Director | 4,988 | · | |
| 2026-04-30 | BERMAN MARTIN KARLA PAOLA | Director | 4,988 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $8.64 | -3.7% | · | $963 | -3.7% |
| 2 months | $8.50 | -2.1% | · | $979 | -2.1% |
| 3 months | $7.67 | +8.5% | $0.07 | $1,094 | +9.4% |
| 6 months | $7.29 | +14.1% | $0.13 | $1,159 | +15.9% |
| 1 year | $7.23 | +15.1% | $0.25 | $1,185 | +18.5% |
| 2 years | $8.59 | -3.1% | $0.49 | $1,026 | +2.6% |
| 3 years | $8.29 | +0.4% | $0.69 | $1,087 | +8.7% |
| 5 years | $5.72 | +45.4% | $0.89 | $1,610 | +61.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ARCO does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.